Company profile: BarioSurg
1.1 - Company Overview
Company description
- Provider of a proprietary, long-term, minimally invasive and reversible medical device, the Gastric Vest System, for bariatric surgeons to address obesity and metabolic disease.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BarioSurg
Genfit
HQ: France
Website
- Description: Provider of innovative therapeutic and diagnostic solutions for metabolic and liver-related diseases, dedicated to discovery and development in areas with considerable unmet medical needs where approved treatments are lacking; a late-stage biopharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genfit company profile →
Altimmune
HQ: United States
Website
- Description: Provider of vaccines and other biological products to address unmet market and public health needs, using proprietary non-invasive intranasal delivery to stimulate robust and durable immune responses for prevention; programs include pemvidutide, a GLP-1/glucagon dual receptor agonist being developed for obesity and for metabolic dysfunction-associated steatohepatitis (MASH). Proof of principle shown in animals and initial human clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altimmune company profile →
Sigilon Therapeutics
HQ: United States
Website
- Description: Provider of immune-privileged, immune-protected engineered human cell products to treat acute and chronic diseases by restoring normal physiology while aiming to avoid fibrosis and immune rejection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sigilon Therapeutics company profile →
Omthera
HQ: United States
Website
- Description: Provider of specialty pharmaceutical therapies in clinical development for dyslipidemia and elevated triglyceride levels, serving patients at increased risk of cardiovascular disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omthera company profile →
Callidus Biopharma
HQ: United States
Website
- Description: Provider of drug discovery focused on best-in-class enzyme replacement therapies for lysosomal storage disorders, using a novel technology platform that attaches a form of naturally occurring Insulin-like Growth Factor (IGF-2) to therapeutic enzymes to enhance targeting to relevant cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Callidus Biopharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BarioSurg
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BarioSurg
2.2 - Growth funds investing in similar companies to BarioSurg
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BarioSurg
4.2 - Public trading comparable groups for BarioSurg
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →